87882 Federal Register / Vol. 89, No. 214 / Tuesday, November 5, 2024 / Notices 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Consideration will be given 

to comments and suggestions submitted 

within 60 days of this publication. 

The Department also seeks public 

comment on the proposed changes 

related to reporting family co-payments. 

Finally, the Department seeks public 

comment on use of the pooling factor for 

CCDF administrative data reporting. The 

current ACF–800 and ACF–801 reports 

instruct states that pool CCDF and nonCCDF funds to report all children and 

families funded by these pooled funding 

sources on both the ACF–800 and ACF– 

801. ACF then applies a pooling factor 

(reported by the state on the ACF–800) 

to determine the number of children 

and families served by CCDF. During 

the public comment period, ACF is 

soliciting comments on this approach, 

or whether it is possible for states to 

identify and separately report all 

children and families served by CCDF 

without the need to apply a pooling 

factor. 

Authority: Section 658K of the Child 

Care and Development Block Grant Act 

(42 U.S.C. 9858); regulations 45 CFR 

98.70 and 98.71. 

Mary C. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2024–25691 Filed 11–4–24; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Lists of Designated Primary Medical 

Care, Mental Health, and Dental Health 

Professional Shortage Areas 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: This notice informs the public 

of the availability of the complete lists 

of all geographic areas, population 

groups, and facilities designated as 

primary medical care, dental health, and 

mental health professional shortage 

areas (HPSAs) in a designated status as 

of October 15, 2024. The lists are 

available on the shortage area topic page 

on HRSA’s data.hrsa.gov website. 

ADDRESSES: Complete lists of HPSAs 

designated as of October 15, 2024, are 

available on the website at https://

data.hrsa.gov/tools/health-workforce/ 

shortage-areas/frn. Frequently updated 

information on HPSAs is available at 

https://data.hrsa.gov/topics/healthworkforce/health-workforce-shortageareas. Information on shortage 

designations is available at https://

bhw.hrsa.gov/workforce-shortage-areas/ 

shortage-designation. 

FOR FURTHER INFORMATION CONTACT: For 

further information on the HPSA 

designations listed on the website or to 

request additional designation, 

withdrawal, or reapplication for 

designation, please contact Dr. Shelby 

Hockenberry, Branch Chief, Shortage 

Designation Branch, Division of Policy 

and Shortage Designation, Bureau of 

Health Workforce, HRSA, 5600 Fishers 

Lane, Rockville, Maryland 20857, sdb@

hrsa.gov, (301) 443–1993. 

SUPPLEMENTARY INFORMATION: 

Background 

Section 332 of the Public Health 

Service (PHS) Act, 42 U.S.C. 254e, 

provides that the Secretary shall 

designate HPSAs based on criteria 

established by regulation. HPSAs are 

defined in section 332 to include (1) 

urban and rural geographic areas with 

shortages of health professionals, (2) 

population groups with such shortages, 

and (3) facilities with such shortages. 

Section 332 further requires that the 

Secretary annually publish lists of the 

designated geographic areas, population 

groups, and facilities. The lists of 

HPSAs are to be reviewed at least 

annually and revised as necessary. 

Final regulations (42 CFR part 5) were 

published on November 17, 1980 (45 FR 

75996), that include the criteria for 

designating HPSAs. Criteria were 

defined for seven health professional 

types: primary medical care, dental, 

psychiatric, vision care, podiatric, 

pharmacy, and veterinary care. The 

criteria for correctional facility HPSAs 

were published on October 29, 1987 (52 

FR 41594), and revised March 2, 1989 

(54 FR 8735). The criteria for psychiatric 

HPSAs were expanded to mental health 

HPSAs on January 22, 1992 (57 FR 

2473). Currently funded PHS Act 

programs use only the primary medical 

care, mental health, or dental HPSA or 

relevant sub-score designations such as 

Maternity Care Target Areas. 

HPSA designation offers access to 

potential federal assistance. Public or 

private nonprofit entities are eligible to 

apply for assignment of National Health 

Service Corps personnel to provide 

primary medical care, mental health, or 

dental health services in or to these 

HPSAs. National Health Service Corps 

health professionals enter into service 

agreements to serve in federally 

designated HPSAs. Entities with clinical 

training sites located in HPSAs are 

eligible to receive priority for certain 

residency training program grants 

administered by HRSA. Other federal 

programs also utilize HPSA 

designations. For example, under 

authorities administered by the Centers 

for Medicare & Medicaid Services, 

certain qualified providers in 

geographic area HPSAs are eligible for 

increased levels of Medicare 

reimbursement. 

Content and Format of Lists 

The three lists of designated HPSAs 

are available on the HRSA Data 

Warehouse shortage area topic web page 

and include a snapshot of all geographic 

areas, population groups, and facilities 

that were designated HPSAs as of 

October 15, 2024. This notice 

incorporates the most recent annual 

reviews of designated HPSAs and 

supersedes the HPSA lists published in 

the Federal Register on July 1, 2024, (89 

FR 54471/Document Number 2024– 

14477). That publication served as a 

notice that if those HPSAs in a proposed 

for withdrawal status were not reevaluated and/or continued to not meet 

designation requirements by the time 

the HPSA Federal Register notice 

published on or before November 1, 

2024, they would be withdrawn. 

In addition, all Indian tribes that meet 

the definition of such tribes in the 

Indian Health Care Improvement Act of 

1976, 25 U.S.C. 1603, are automatically 

designated as population groups with 

primary medical care and dental health 

professional shortages. Further, the 

Health Care Safety Net Amendments of 

2002 provides eligibility for automatic 

facility HPSA designations for all 

federally qualified health centers 

(FQHCs) and rural health clinics that 

offer services regardless of ability to 

pay. Specifically, these entities include 

FQHCs funded under section 330 of the 

PHS Act, FQHC Look-Alikes, and tribal 

and urban Indian clinics operating 

under the Indian Self-Determination 

and Education Act of 1975 (25 U.S.C. 

450) or the Indian Health Care 

Improvement Act. Many, but not all, of 

these entities are included on this 

listing. Absence from this list does not 

exclude them from HPSA designation; 

facilities eligible for automatic 

designation are included in the database 

when they are identified. 

Each list of designated HPSAs is 

arranged by state. Within each state, the 

list is presented by county. If only a 

portion (or portions) of a county is (are) 

designated, a county is part of a larger 

designated service area, or a population 

group residing in a county or a facility 

located in the county has been 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 214 / Tuesday, November 5, 2024 / Notices 87883 

designated, the name of the service area, 

population group, or facility involved is 

listed under the county name. A county 

that has a whole county geographic or 

population group HPSA is indicated by 

the phrase ‘‘County’’ following the 

county name. 

Development of the Designation and 

Withdrawal Lists 

HRSA continuously receives requests 

for designation or withdrawal of a 

particular geographic area, population 

group, or facility as a HPSA. Under a 

Cooperative Agreement between HRSA 

and the 54 state and territorial primary 

care offices (PCOs), PCOs conduct needs 

assessments and submit applications to 

HRSA to designate HPSAs. HRSA refers 

requests that come from other sources to 

PCOs for review. In addition, interested 

parties, including governors, state 

primary care associations, and state 

professional associations, are notified of 

requests so that they may submit their 

comments and recommendations. 

HRSA reviews each recommendation 

for possible addition, continuation, 

revision, or withdrawal. Following 

review, HRSA notifies the appropriate 

agency, individuals, and interested 

organizations of each designation of a 

HPSA, rejection of recommendation for 

HPSA designation, revision of a HPSA 

designation, and/or advance notice of 

pending withdrawals from the HPSA 

list. Designations (or revisions of 

designations) are effective as of the date 

on the notification from HRSA and are 

updated daily on the HRSA Data 

Warehouse website. The effective date 

of a withdrawal will be the next 

publication of a notice regarding the list 

of designated HPSAs in the Federal 

Register. 

Diana Espinosa, 

Principal Deputy Administrator. 

[FR Doc. 2024–25624 Filed 11–4–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Secretary; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Interagency Pain 

Research Coordinating Committee. 

The meeting will be held as a virtual 

meeting and will be open to the public 

as indicated below. Individuals who 

plan to view the virtual meeting and 

need special assistance or other 

reasonable accommodations to view the 

meeting, should notify the Contact 

Person listed below in advance of the 

meeting. The meeting can be accessed 

from the NIH Videocast at the following 

link: https://videocast.nih.gov/. 

Name of Committee: Interagency Pain 

Research Coordinating Committee. 

Date: December 4, 2024. 

Time: 10:15 a.m. to 4:00 p.m. Eastern Time 

(ET). 

Agenda: Interagency Pain Research 

Coordinating Committee member updates 

and other committee business, including 

Federal Pain Research Strategy research 

progress, communication and dissemination 

strategies, and workgroup updates. 

Webcast Live: http://videocast.nih.gov/. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Contact Person: Leah Pogorzala, Ph.D., 

Policy Analyst, Office of Pain Policy and 

Planning, Office of the Director, National 

Institute of Neurological Disorders and 

Stroke, NIH, Bethesda, MD 20892, Phone: 

(301) 496–4228, Email: leah.pogorzala@

nih.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Written comments should be submitted 

to the contact person by 5:00 p.m. ET on 

November 27, 2024. 

Information is also available on the 

IPRCC website http://iprcc.nih.gov, 

where an agenda and any additional 

information for the meeting will be 

posted when available. 

Dated: October 30, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–25650 Filed 11–4–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following Meetings. 

The Meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Developmental Biology. 

Date: December 2, 2024. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Anne Marie Strohecker, 

Ph.D., Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 867–5309, 

stroheckeram@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Health Services and Systems B. 

Date: December 3–4, 2024. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Tara Roshell Earl, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1007C, 

Bethesda, MD 20892, (301) 402–6857, earltr@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Microbial Diagnostics, Detection 

and Decontamination. 

Date: December 3–4, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Shinako Takada, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–827–5997, shinako.takada@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Special topics in Mechanistic and 

Clinical Neuroscience. 

Date: December 3, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health 6701 

Rockledge Drive, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Suzan Nadi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5217B, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1259, nadis@csr.nih.gov. 


ddrumheller on DSK120RN23PROD with NOTICES1